About Cognivia
Cognivia is a company based in Mont-saint-guibert (Belgium) founded in 2013. Cognivia has raised $16.5 million across 1 funding round from investors including Vesalius Biocapital Partners, SFPIM International and Wallonie Entreprendre. The company has 16 employees as of December 31, 2022. Cognivia offers products and services including Placebell and Compl-AI. Cognivia operates in a competitive market with competitors including Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Yunu, among others.
- Headquarter Mont-saint-guibert, Belgium
- Employees 16 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Tools4patient Sa
-
Annual Revenue
Not available
-
Net Profit
-$1.28 M (USD)6as on Dec 31, 2022
-
EBITDA
-$374.99 K (USD)16as on Dec 31, 2022
-
Total Equity Funding
$16.5 M (USD)
in 1 rounds
-
Latest Funding Round
$16.5 M (USD), Series B
Apr 18, 2024
-
Investors
Vesalius Biocapital Partners
& 2 more
-
Employee Count
16
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cognivia
Cognivia offers a comprehensive portfolio of products and services, including Placebell and Compl-AI.
Reduces placebo response and data variability in clinical trials.
Predicts nonadherence and dropout risks to improve patient engagement.
Funding Insights of Cognivia
Cognivia has successfully raised a total of $16.5M through 1 strategic funding round. The most recent funding activity was a Series B round of $16.5 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cognivia
Cognivia has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Vesalius Biocapital Partners, SFPIM International and Wallonie Entreprendre.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
SFPIM International is engaged in co-financing Belgian companies abroad.
|
Locked | Locked | Locked | |
|
Life sciences-focused VC firm investing in Europe and Canada
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Cognivia
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cognivia
Investment portfolio details for Cognivia
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cognivia
Detailed financials for Cognivia
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cognivia Comparisons
Peer comparison for Cognivia
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cognivia
Cognivia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clario, Lightship, SFJ Pharmaceuticals, N-Power Medicine and Yunu, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CRO focused on providing clinical trial supply services for biopharma sector
|
|
| Locked | Locked | Locked |
Direct-to-patient clinical trial solutions are provided by Lightship.
|
|
| Locked | Locked | Locked |
Specialty pharmaceutical company based on partnering model
|
|
| Locked | Locked | Locked |
Clinical trial services are provided to support medical research initiatives.
|
|
| Locked | Locked | Locked |
Clinical trial imaging workflow and data management technology is provided.
|
Detailed competitors of Cognivia
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cognivia
Complete news archive for Cognivia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cognivia
Cognivia was founded in 2013 and raised its 1st funding round 11 years after it was founded.
Cognivia is headquartered in Mont-saint-guibert, Belgium.
Dominique Demolle is the current CEO of Cognivia.
Cognivia is a funded company, having raised a total of $16.5M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Cognivia is 16.
Founded in 2013 and based in Mont Saint Guibert, Belgium, Cognivia operates in the health technology sector. Data modeling solutions are developed to predict patient behavior and drug responses, addressing variability from placebo effects and patient heterogeneity. Tools for forecasting nonadherence and dropout risks are also offered, supporting patient engagement and enhancing study power for clinical development decisions.
Cognivia's top competitors include Lightship, SFJ Pharmaceuticals and N-Power Medicine.
Cognivia offers Placebell and Compl-AI.
Cognivia has 3 investors. Key investors include Vesalius Biocapital Partners, SFPIM International, and Wallonie Entreprendre.